Private‑equity veteran Matt Holt is steering his Thoreau Group toward a purchase of Ensemble Health Partners that would value the health‑services firm at roughly $12 billion. Sources say negotiations have moved beyond preliminary offers, indicating both sides see strategic fit. Closing a deal of this magnitude would mark one of the largest recent private‑equity entries into the healthcare advisory space.

Ensemble Health, known for its network‑based cost‑management platform, has attracted interest as hospitals and insurers seek more integrated solutions to contain spending. Holt’s track record of scaling niche operators suggests he could inject capital and operational expertise to broaden the firm’s reach. The transaction, if completed, would likely reshape competitive dynamics, prompting rivals to reassess their own consolidation strategies.

Investors are watching the talks closely because a successful bid would boost Thoreau Group’s assets under management and could set a pricing benchmark for similar deals. The market reaction will hinge on how quickly the parties can finalize terms and whether regulatory scrutiny arises. For now, the advanced talks signal a decisive move toward a high‑profile consolidation in health‑care services.